266 related articles for article (PubMed ID: 22077694)
1. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
[TBL] [Abstract][Full Text] [Related]
2. Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies.
Van Neste L; Partin AW; Stewart GD; Epstein JI; Harrison DJ; Van Criekinge W
Prostate; 2016 Sep; 76(12):1078-87. PubMed ID: 27121847
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer.
Fiano V; Zugna D; Grasso C; Trevisan M; Delsedime L; Molinaro L; Cassoni P; Papotti M; Merletti F; Akre O; Pettersson A; De Marco L; Richiardi L
Clin Epigenetics; 2019 Oct; 11(1):152. PubMed ID: 31666119
[TBL] [Abstract][Full Text] [Related]
4. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies.
Partin AW; Van Neste L; Klein EA; Marks LS; Gee JR; Troyer DA; Rieger-Christ K; Jones JS; Magi-Galluzzi C; Mangold LA; Trock BJ; Lance RS; Bigley JW; Van Criekinge W; Epstein JI
J Urol; 2014 Oct; 192(4):1081-7. PubMed ID: 24747657
[TBL] [Abstract][Full Text] [Related]
5. Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy.
Zelic R; Fiano V; Zugna D; Grasso C; Delsedime L; Daniele L; Galliano D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Clin Cancer Res; 2016 Feb; 22(4):984-92. PubMed ID: 26475336
[TBL] [Abstract][Full Text] [Related]
6. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
7. Combined hypermethylation of APC and GSTP1 as a molecular marker for prostate cancer: quantitative pyrosequencing analysis.
Yoon HY; Kim SK; Kim YW; Kang HW; Lee SC; Ryu KH; Shon HS; Kim WJ; Kim YJ
J Biomol Screen; 2012 Aug; 17(7):987-92. PubMed ID: 22511308
[TBL] [Abstract][Full Text] [Related]
8. Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies.
Harden SV; Sanderson H; Goodman SN; Partin AA; Walsh PC; Epstein JI; Sidransky D
J Natl Cancer Inst; 2003 Nov; 95(21):1634-7. PubMed ID: 14600096
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
[TBL] [Abstract][Full Text] [Related]
10. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.
Stewart GD; Van Neste L; Delvenne P; Delrée P; Delga A; McNeill SA; O'Donnell M; Clark J; Van Criekinge W; Bigley J; Harrison DJ
J Urol; 2013 Mar; 189(3):1110-6. PubMed ID: 22999998
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.
Gonzalgo ML; Pavlovich CP; Lee SM; Nelson WG
Clin Cancer Res; 2003 Jul; 9(7):2673-7. PubMed ID: 12855646
[TBL] [Abstract][Full Text] [Related]
16. Methylation of APC and GSTP1 in non-neoplastic tissue adjacent to prostate tumour and mortality from prostate cancer.
Richiardi L; Fiano V; Grasso C; Zugna D; Delsedime L; Gillio-Tos A; Merletti F
PLoS One; 2013; 8(7):e68162. PubMed ID: 23874531
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
[TBL] [Abstract][Full Text] [Related]
18. Prospective diagnostic efficiency of biopsy washing DNA GSTP1 island hypermethylation for detection of adenocarcinoma of the prostate.
Eilers T; Machtens S; Tezval H; Blaue C; Lichtinghagen R; Hagemann J; Jonas U; Serth J
Prostate; 2007 May; 67(7):757-63. PubMed ID: 17373715
[TBL] [Abstract][Full Text] [Related]
19. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.
Rogers CG; Gonzalgo ML; Yan G; Bastian PJ; Chan DY; Nelson WG; Pavlovich CP
J Urol; 2006 Nov; 176(5):2280-4. PubMed ID: 17070312
[TBL] [Abstract][Full Text] [Related]
20. The investigation of GSTP1, APC and RASSF1 gene promoter hypermethylation in urine DNA of prostate-diseased patients.
Haluskova J; Lachvac L; Nagy V
Bratisl Lek Listy; 2015; 116(2):79-82. PubMed ID: 25665470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
